Access cutting-edge t-cell and nk-cell neoplasm treatment through this clinical trial at a research site in Denver. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Denver location
Preparing your pre-screening questions…
Access t-cell and nk-cell neoplasm specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related t-cell and nk-cell neoplasm treatment provided free
Check if you qualify for this t-cell and nk-cell neoplasm clinical trial in Denver, CO
No-Cost Study Care
Local to Denver
Convenient for CO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this observational study is to correlate molecular alterations with outcomes including overall survival (OS), progression-free survival (PFS), response rates for patients with a new diagnosis, primary refractory or relapse, of mature T-cell and NK-cell neoplasms (TNKL). We hypothesize that machine learning can be leveraged to uncover distinct genetic vulnerabilities that underlie treatment response and resistance for patients with TNKL, thus moving towards personalized treatment solutions.
Sponsor: Massachusetts General Hospital
Yes, this clinical trial (NCT06067347) has an active research site in Denver, CO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for t-cell and nk-cell neoplasm treatment options in Denver, CO, this clinical trial (NCT06067347) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Denver research site is actively enrolling participants for this clinical trial. You'll receive care from experienced t-cell and nk-cell neoplasm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all t-cell and nk-cell neoplasm clinical trials near you to find additional studies recruiting in your area.
See all ankylosing spondylitis clinical trials recruiting in Denver — not just this study.
Browse Ankylosing Spondylitis Trials in Denver →